Response of advanced HCC to pembrolizumab and lenvatinib combination therapy despite monotherapy failure

Schulte, N; Li, MY; Zhan, TZ; Dreikhausen, L; Sollors, J; Antoni, C; Diehl, S; Schoenberg, SO; Rahbari, N; Reissfelder, C; Giordano, FA; Ebert, MP; Teufel, A

Teufel, A (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Div Hepatol,Dept Med 2, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.

ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020; 58 (08): 773

Abstract

In recent years, immune checkpoint inhibitors (ICIs) were successfully introduced to cancer therapy, and these drugs have already become essential for......

Full Text Link